Somatic ARID1A, MLL3 and NF1 mutations were found in at least one component in three, six and four breast tumours, respectively, and the presence of these mutations was unrelated to the HER2 status (Fig. S2, Table 2). The gene discussed is ERBB2; the disease is breast neoplasm.